Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
Clinical trial NCT04497792 · COMPLETED
Trial details
- NCT number
- NCT04497792
- Sponsor
- Research Institute for Complex Problems of Cardiovascular Diseases, Russia
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.